Synaptic transmission block by presynaptic injection of oligomeric amyloid beta

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 14, 2009, Pages 5901-5906

  Moreno, Herman ^a,b   Yu, Eunah ^b,c   Pigino, Gustavo ^b,d   Hernandez, Alejandro I ^a   Kim, Natalia ^a   Moreira, Jorge E ^b,e   Sugimori, Mutsuyuki ^b,c   Llinás, Rodolfo R ^b,c  

^a SUNY Downstate Medical Center   (United States)

^b MARINE BIOLOGICAL LABORATORY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Alzheimer's disease; Fluorescence microscopy; Presynaptic voltage clamp squid giant synapse; Ultrastructure

Indexed keywords

AMYLOID BETA PROTEIN; CASEIN KINASE;

ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; COATED VESICLE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOCYTOSIS; NONHUMAN; PHENOTYPE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN FUNCTION; SQUID; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION;

AMYLOID BETA-PEPTIDES; ANIMALS; CASEIN KINASE II; DECAPODIFORMES; ELECTROPHYSIOLOGY; ENDOCYTOSIS; MICROSCOPY, ELECTRON; PEPTIDE FRAGMENTS; PRESYNAPTIC TERMINALS; SYNAPTIC TRANSMISSION;

CEPHALOPODA;

EID: 65249174019     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900944106     Document Type: Article

References (39)

1. Hutton M, Pérez-Tur J, Hardy J (1998) Genetics of Alzheimer's disease. Essays Biochem 33:117-131. Review.
2. Younkin SG (1998) The role of A beta 42 in Alzheimer's disease. J Physiol Paris 92:289-292.
3. Sisodia SS, Kim SH, Thinakaran G (1999) Function and dysfunction of the presenilins. Am J Hum Genet 65:7-12.
4. Selkoe DJ (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81:741-766.
5. LaFerla FM, Green KN, OddoS(2007) Intracellular amyloid-beta in Alzheimer's disease. Nat Rev Neurosci 8:499-509.
6. Giannakopoulos P, et al. (2003) Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer's disease. Neurology 60:1495-1500.
7. Steinerman JR, et al. (2008) Distinct pools of beta-amyloid in Alzheimer diseaseaffected brain: A clinicopathologic study. Arch Neurol 65:906-912.
8. Lee EB, et al. (2005) BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo. J Cell Biol 168:291-302.
9. Llinás R, Steinberg IZ, Walton K (1981) Relationship between presynaptic calcium current and postsynaptic potential in squid giant synapse. Biophys J 33:323-351.
10. KusanoK,LandauEM(1975) Depression and recoveryoftransmissionatthe squid giant synapse. J Physiol 245:13-32
11. Daly C, Sugimori M, Moreira JE, Ziff EB, Llinás R (2000) Synaptophysin regulates clathrin-independent endocytosis ofsynaptic vesicles. Proc Natl Acad Sci USA 97:6120-6125.
12. Puzzo D, et al. (2005) Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 25:6887-6897.
13. Chang KA, Suh YH (2005) Pathophysiological roles of amyloidogenic carboxy-terminal fragments of the beta-amyloid precursor protein in Alzheimer's disease. J Pharmacol Sci 97:461-471.
14. Petersen RB, et al. (2007) Signal transduction cascades associated with oxidative stress in Alzheimer's disease. J Alzheimers Dis 11:143-152.
15. Milton NG (2005) Phosphorylated amyloid-beta: The toxic intermediate in alzheimer's disease neurodegeneration. Subcell Biochem 38:381-402.
16. Raftery M, et al. (2005) Phosphorylation of apolipoprotein-E at an atypical protein kinase CK2 PSD/E site in vitro. Biochemistry 44:7346-7353.
17. Hilfiker S, Pieribone VA, Nordstedt C, Greengard P, Czernik AJ (1999) Regulation of synaptotagmin I phosphorylation by multiple protein kinases. J Neurochem 73:921-932.
18. Lieberman DN, Mody I (1999) Casein kinase-II regulates NMDA channel function in hippocampal neurons. Nat Neurosci 2:125-132.
19. Takahashi M, Amin N, Grant P, Pant HC(1995) P13suc1 associates withacdc2-like kinase in a multimeric cytoskeletal complex in squid axoplasm. J Neurosci 15:6222-6229.
20. Coleman PD, Yao PJ (2003) Synaptic slaughter in Alzheimer's disease. Neurobiol Aging 24:1023-1027.
21. Hardy JA, Higgins GA (1992) Alzheimer's disease: The amyloid cascade hypothesis. Science 256:184-185.
22. Gouras GK, Almeida CG, Takahashi RH (2005) Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 26:1235-1244.
23. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat Genet 9:21-30.
24. D'Andrea MR, Nagele RG, Wang HY, Peterson PA, Lee DH (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38:120-134.
25. Bahr BA, et al. (1998) Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J Comp Neurol 397:139-147.
26. Takahashi RH, et al. (2004) Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592-3599.
27. LeBlanc AC, XueR,GambettiP(1996) Amyloid precursor protein metabolisminprimary cell cultures of neurons, astrocytes, and microglia. J Neurochem 6:2300-2310.
28. Llinas R (1999) The Squid Giant Synapse: A Model for Chemical Transmission (Oxford Univ Press, New York).
29. Li QX, et al. (1999) Intracellular accumulation of detergent-soluble amyloidogenic A beta fragment of Alzheimer's disease precursor protein in the hippocampus of aged transgenic mice. J Neurochem 72:2479-2487.
30. Almeida CG, Takahashi RH, Gouras GK (2006) Beta-amyloid accumulation impairs multivesicular body sorting by inhibiting the ubiquitin-proteasome system. J Neurosci 26:4277-4288.
31. Adalbert R, Gilley J, Coleman MP (2007) Abeta, tau and ApoE4 in Alzheimer's disease: The axonal connection. Trends Mol Med 13:135-142.
32. Muresan Z, Muresan V (2006) Neuritic deposits of amyloid-beta peptide in a subpopulation of central nervous system-derived neuronal cells. Mol Cell Biol 26:4982-4997.
33. Stokin GB, et al. (2005) Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science 307:1282-1288.
34. Lazarov O,et al. (2005) Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: Revisited. J Neurosci 25:2386-2395.
35. Li L, Liu J, Suo WZ (2008) GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice. J Neuroinflammation 5:24.
36. Song MS, Saavedra L, de Chaves EI (2006) Apoptosis is secondary to non-apoptotic axonal degeneration in neurons exposed to Abeta in distal axons. Neurobiol Aging 27:1224-1238.
37. Blanquet PR (2000) Casein kinase 2 as a potentially important enzyme in the nervous system. Prog Neurobiol 60:211-246.
38. Stine WB, Jr, Dahlgren KN, Krafft GA, LaDu MJ (2003) In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis. J Biol Chem 278:11612-11622.
39. Pigino G, et al. (2009) Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta. Proc Natl Acad Sci USA, in press.